{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:13:05Z","timestamp":1769875985534,"version":"3.49.0"},"reference-count":39,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2019,2,26]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Pain-relief prescriptions have led to an alarming increase in drug-related\nabuse.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p> In this study, we estimate the pain reliever prescription rates at a major German academic\nhospital center and compare with the nationwide trends from Germany and prescription reports from\nthe USA.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>  We analysed &gt;500,000 discharge summaries from Charit\u00e9, encompassing the years 2006\nto 2015, and extracted the medications and diagnoses from each discharge summary. Prescription\nreports from the USA and Germany were collected and compared with the trends at Charit\u00e9 to identify\nthe frequently prescribed pain relievers and their world-wide utilization trends. The average\ncosts of pain therapy were also calculated and compared between the three regions.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>  Metamizole (dipyrone), a non-opioid analgesic, was the most commonly prescribed pain\nreliever at Charit\u00e9 (59%) and in Germany (23%) while oxycodone (29%), a semi-synthetic opioid,\nwas most commonly ordered in the USA. Surprisingly, metamizole was prescribed to nearly 20% of\nall patients at Charit\u00e9, a drug that has been banned for safety reasons (agranulocytosis) in most developed\ncountries including Canada, United Kingdom, and USA. A large number of prospective\ncases with high risk for agranulocytosis and other side effects were found. The average cost of pain\ntherapy greatly varied between the USA (125.3 EUR) and Charit\u00e9 (17.2 EUR).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The choice of pain relievers varies regionally and is often in disagreement with approved\nindications and regulatory guidelines. A pronounced East-West gradient was observed with\nmetamizole use and the opposite with prescription opioids.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874473711666180911091846","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:06:11Z","timestamp":1536753971000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Pain-Prescription Differences - An Analysis of 500,000 Discharge Summaries"],"prefix":"10.2174","volume":"11","author":[{"given":"Saskia","family":"Preissner","sequence":"first","affiliation":[{"name":"Dental, Oral and Maxillary Medicine, Department of Operative Dentistry, Charite \u2013 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal B.","family":"Siramshetty","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Group, Experimental and Clinical Research Centre, Charite \u2013 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Dunkel","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Group, Institute of Physiology, Charite \u2013 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Steinborn","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Group, Experimental and Clinical Research Centre, Charite \u2013 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedrich C.","family":"Luft","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Research Centre and Max-Delbr\u00fcck Centre for Molecular Medicine, Berlin, Germany; The Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Preissner","sequence":"additional","affiliation":[{"name":"Structural Bioinformatics Group, Experimental and Clinical Research Centre, Charite \u2013 University Medicine Berlin, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"","year":"","unstructured":".   AAPM Facts and Figures on Pain 2016 Available from:"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/15360288.2015.1047553","volume":"29","author":"Brennan F.","year":"2015","unstructured":"Brennan F.  The US Congressional \u201cDecade on Pain Control and Research\u201d 2001-2011: A Review.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14740338.2016.1177509","volume":"15","author":"Harned M.","year":"2016","unstructured":"Harned M, Sloan P.  Safety concerns with long-term opioid use.","journal-title":"Expert Opin Drug Saf"},{"key":"ref=4","author":"Dowell D","year":"","unstructured":"Dowell D, Haegerich TM, Chou R.   CDC Guideline for Prescribing\nOpioids for Chronic Pain - United States, 2016. MMWR Recommendations\nand reports: Morbidity and mortality weekly report\nRecommendations and reports 2016; 65(1): 1-49."},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","volume":"18","author":"Casati A.","year":"2012","unstructured":"Casati A, Sedefov R, Pfeiffer-Gerschel T.  Misuse of medicines in the European Union: A systematic review of the literature.","journal-title":"Eur Addict Res"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.drugpo.2014.07.009","volume":"25","author":"Weisberg D.F.","year":"2014","unstructured":"Weisberg DF, Becker WC, Fiellin DA, Stannard C.  Prescription opioid misuse in the United States and the United Kingdom: Cautionary lessons.","journal-title":"Int J Drug Policy"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187447370801150611184218","volume":"8","author":"van Amsterdam J.","year":"2015","unstructured":"van Amsterdam J, van den Brink W.  The Misuse of Prescription Opioids: A Threat for Europe?","journal-title":"Curr Drug Abuse Rev"},{"key":"ref=8","author":"","year":"","unstructured":"Addiction TEMCfDaD. 2011 Annual report on the state of the\ndrugs problem in Europe 2011 [Available from: http:\/\/www. emcdda.\neuropa.eu\/publications\/annual-report\/2011 (Accessed on 3rd\nSep, 2018)."},{"key":"ref=9","first-page":"45","volume":"110","author":"Schubert I.","year":"2013","unstructured":"Schubert I, Ihle P, Sabatowski R.  Increase in opiate prescription in Germany between 2000 and 2010: A study based on insurance data.","journal-title":"Dtsch Arztebl Int"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.joca.2016.01.135","volume":"24","author":"Smith S.R.","year":"2016","unstructured":"Smith SR, Deshpande BR, Collins JE, Katz JN, Losina E.  Comparative pain reduction of oral non-steroidal anti-inflammatory drugs and opioids for knee osteoarthritis: systematic analytic review.","journal-title":"Osteoarthritis Cartilage"},{"key":"ref=11","first-page":"118","volume":"26","author":"Torres L.M.","year":"2001","unstructured":"Torres LM, Rodr\u00edguez MJ, Montero A.  Efficacy and safety of dipyrone versus tramadol in the management of pain after hysterectomy: A randomized, double-blind, multicenter study.","journal-title":"Reg Anesth Pain Med"},{"key":"ref=12","author":"","year":"","unstructured":"Introduction to Drug Utilisation Research 2016. [Available from:\nhttp:\/\/www.whocc.no\/filearchive\/ publications\/ drug_utilization_\nresearch.pdf"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1365-2125.2011.04045.x","volume":"72","author":"Neubert A.","year":"2011","unstructured":"Neubert A, Hsia Y, de Jong-van den Berg LT.  Comparison of anti-diabetic drug prescribing in children and adolescents in seven European countries.","journal-title":"Br J Clin Pharmacol"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","volume":"121","author":"Rani F.","year":"2008","unstructured":"Rani F, Murray ML, Byrne PJ, Wong IC.  Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom.","journal-title":"Pediatrics"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s10067-016-3239-4","volume":"35","author":"Zamora-Legoff J.A.","year":"2016","unstructured":"Zamora-Legoff JA, Achenbach SJ, Crowson CS, Krause ML, Davis JM, Matteson EL.  Opioid use in patients with rheumatoid arthritis 2005-2014: A population-based comparative study.","journal-title":"Clin Rheumatol"},{"key":"ref=16","author":"","year":"","unstructured":"Arzneiverordnungs-Report 2015. Schwabe U, Paffrath D, editors:\nSpringer: Berlin Heidelberg; 2015."},{"key":"ref=17","author":"","year":"","unstructured":".  Statista. Top pain drugs in the United States based on revenue in\n2011-2012 (in million U.S. dollars) 2012 [Available from:"},{"key":"ref=18","author":"","year":"","unstructured":"WHO Drug Information 2016. Available from: http:\/\/www.\nwho.int\/medicines\/publications\/druginformation\/issues\/DrugInform\nation2016_Vol30-2\/en\/ (Accessed on 3rd Sep, 2018)."},{"key":"ref=19","author":"","year":"","unstructured":".   2015. Consolidated List of Products - Whose Consumption and\/or\nSale Have Been Banned, Withdrawn, Severely Restricted or Not\nApproved by Governments, Twelfth Issue - Pharmaceuticals.\nUnited Nations - New York, 2005."},{"key":"ref=20","author":"","year":"","unstructured":".  2015. Consolidated List of Products - Whose Consumption and\/or\nSale Have Been Banned, Withdrawn, Severely Restricted or Not\nApproved by Governments, Twelfth Issue - Pharmaceuticals.\nUnited Nations - New York, 2005"},{"key":"ref=21","author":"","year":"","unstructured":"Narcotic Drugs - Technical Reports 2015."},{"key":"ref=22","author":"DiMarco M.","year":"","unstructured":"DiMarco M. DiMarco M. Data Maps 2016. Available from:\nhttps:\/\/datamaps. github.io (Accessed on 3rd Sep, 2018)."},{"key":"ref=23","author":"","year":"","unstructured":"(National Average Drug Acquisition Cost) 2016. Available from:\nhttps:\/\/data.medicaid.gov\/Drug-Prices\/NADAC-National-Average-\nDrug-Acquisition-Cost-\/a4y5-998d (Accessed on 3rd Sep, 2018)."},{"key":"ref=24","author":"","year":"","unstructured":"Age and Sex Composition in the United States: 2013 2013 [Available\nfrom: [Available from: https:\/\/www.census.gov\/population\/\nage\/ data\/ 2013 comp.html (Accessed on 3rd Sep, 2018)."},{"key":"ref=25","author":"","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration.\nCenter for Behavioral Health Statistics and Quality National\nSurvey on Drug Use and Health. ICPSR36361-v1. Inter-university\nConsortium for Political and Social Research (ICPSR) 2014.","journal-title":"Center for Behavioral Health Statistics and Quality National Survey on Drug Use and Health ICPSR36361-v1 Inter-university Consortium for Political and Social Research"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","volume":"44","author":"Siramshetty V.B.","year":"2016","unstructured":"Siramshetty VB, Nickel J, Omieczynski C, Gohlke BO, Drwal MN, Preissner R.  WITHDRAWN--a resource for withdrawn and discontinued drugs.","journal-title":"Nucleic Acids Res"},{"key":"ref=27","first-page":"393","volume":"6","author":"Johnson M.","year":"2013","unstructured":"Johnson M, Collett B, Castro-Lopes JM.  The challenges of pain management in primary care: a pan-European survey.","journal-title":"J Pain Res"},{"key":"ref=28","first-page":"11","volume":"46","author":"Johnson S.R.","year":"2016","unstructured":"Johnson SR.  New CDC guidelines are unlikely to affect opioid prescribing practices.","journal-title":"Mod Healthc"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"Berterame S.","year":"2016","unstructured":"Berterame S, Erthal J, Thomas J.  Use of and barriers to access to opioid analgesics: A worldwide, regional, and national study.","journal-title":"Lancet"},{"key":"ref=30","first-page":"627","volume":"113","author":"Mo\u00dfhammer D.","year":"2016","unstructured":"Mo\u00dfhammer D, Haumann H, M\u00f6rike K, Joos S.  Polypharmacy-an upward trend with unpredictable effects.","journal-title":"Dtsch Arztebl Int"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/01.smj.0000233020.68212.8f","volume":"99","author":"Garcia S.","year":"2006","unstructured":"Garcia S, Canoniero M, Lopes G, Soriano AO.  Metamizole use among Hispanics in Miami: Report of a survey conducted in a primary care setting.","journal-title":"South Med J"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/ewjm.175.3.159","volume":"175","author":"Taylor L.","year":"2001","unstructured":"Taylor L, Abarca S, Henry B, Friedman L.  Use of Neo-melubrina, a banned antipyretic drug, in San Diego, California: A survey of patients and providers.","journal-title":"West J Med"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/jcpt.12422","volume":"41","author":"Andrade S.","year":"2016","unstructured":"Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J.  Safety of metamizole: A systematic review of the literature.","journal-title":"J Clin Pharm Ther"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00228-014-1777-8","volume":"71","author":"Huber M.","year":"2015","unstructured":"Huber M, Andersohn F, Sarganas G.  Metamizole-induced agranulocytosis revisited: Results from the prospective Berlin Case-Control Surveillance Study.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00228-014-1781-z","volume":"71","author":"Blaser L.S.","year":"2015","unstructured":"Blaser LS, Tramonti A, Egger P, Haschke M, Kr\u00e4henb\u00fchl S, R\u00e4tz Bravo AE.  Hematological safety of metamizole: Retrospective analysis of WHO and Swiss spontaneous safety reports.","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=36","first-page":"PI93","volume":"10","author":"Maj S.","year":"2004","unstructured":"Maj S, Centkowski P.  A prospective study of the incidence of agranulocytosis and aplastic anemia associated with the oral use of metamizole sodium in Poland.","journal-title":"Med Sci Monit"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/147323000203000504","volume":"30","author":"Maj S.","year":"2002","unstructured":"Maj S, Lis Y.  The incidence of metamizole sodium-induced agranulocytosis in Poland.","journal-title":"J Int Med Res"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"e0122918","DOI":"10.1371\/journal.pone.0122918","volume":"10","author":"K\u00f6tter T.","year":"2015","unstructured":"K\u00f6tter T, da Costa BR, F\u00e4ssler M.  Metamizole-associated adverse events: A systematic review and meta-analysis.","journal-title":"PLoS One"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pds.697","volume":"11","author":"B\u00e4ckstr\u00f6m M.","year":"2002","unstructured":"B\u00e4ckstr\u00f6m M, H\u00e4gg S, Mj\u00f6rndal T, Dahlqvist R.  Utilization pattern of metamizole in northern Sweden and risk estimates of agranulocytosis.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/165261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T09:21:59Z","timestamp":1557998519000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/165261\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874473711666180911091846","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}